nodes	percent_of_prediction	percent_of_DWPC	metapath
Acebutolol—Atenolol—Procarbazine—hematologic cancer	0.238	1	CrCrCtD
Acebutolol—SLC22A1—hematologic cancer	0.226	0.775	CbGaD
Acebutolol—ABCB1—hematologic cancer	0.0656	0.225	CbGaD
Acebutolol—SLC22A1—Cytarabine—hematologic cancer	0.03	0.102	CbGbCtD
Acebutolol—SLC22A1—Cladribine—hematologic cancer	0.0283	0.0967	CbGbCtD
Acebutolol—SLC22A1—Imatinib—hematologic cancer	0.0261	0.0889	CbGbCtD
Acebutolol—ABCB1—Lenalidomide—hematologic cancer	0.0178	0.0606	CbGbCtD
Acebutolol—CYP2D6—Lomustine—hematologic cancer	0.0156	0.0531	CbGbCtD
Acebutolol—CYP2D6—Idarubicin—hematologic cancer	0.0139	0.0473	CbGbCtD
Acebutolol—CYP2D6—Hydroxyurea—hematologic cancer	0.0118	0.0403	CbGbCtD
Acebutolol—ABCB1—Daunorubicin—hematologic cancer	0.0104	0.0356	CbGbCtD
Acebutolol—CYP2D6—Bortezomib—hematologic cancer	0.0103	0.035	CbGbCtD
Acebutolol—ABCB1—Alitretinoin—hematologic cancer	0.0102	0.0348	CbGbCtD
Acebutolol—ABCB1—Imatinib—hematologic cancer	0.00799	0.0272	CbGbCtD
Acebutolol—CYP2D6—Imatinib—hematologic cancer	0.00753	0.0257	CbGbCtD
Acebutolol—ABCB1—Nilotinib—hematologic cancer	0.00726	0.0247	CbGbCtD
Acebutolol—ABCB1—Vinorelbine—hematologic cancer	0.0072	0.0245	CbGbCtD
Acebutolol—CYP2D6—Nilotinib—hematologic cancer	0.00684	0.0233	CbGbCtD
Acebutolol—CYP2D6—Vinorelbine—hematologic cancer	0.00678	0.0231	CbGbCtD
Acebutolol—ABCB1—Dasatinib—hematologic cancer	0.00641	0.0219	CbGbCtD
Acebutolol—ABCB1—Mitoxantrone—hematologic cancer	0.00634	0.0216	CbGbCtD
Acebutolol—ABCB1—Betamethasone—hematologic cancer	0.00565	0.0193	CbGbCtD
Acebutolol—ABCB1—Gemcitabine—hematologic cancer	0.0056	0.0191	CbGbCtD
Acebutolol—ABCB1—Prednisolone—hematologic cancer	0.00557	0.019	CbGbCtD
Acebutolol—ABCB1—Prednisone—hematologic cancer	0.00526	0.0179	CbGbCtD
Acebutolol—ABCB1—Irinotecan—hematologic cancer	0.00499	0.017	CbGbCtD
Acebutolol—ABCB1—Vinblastine—hematologic cancer	0.00444	0.0151	CbGbCtD
Acebutolol—ABCB1—Vincristine—hematologic cancer	0.00436	0.0149	CbGbCtD
Acebutolol—CYP2D6—Vinblastine—hematologic cancer	0.00418	0.0142	CbGbCtD
Acebutolol—ABCB1—Cisplatin—hematologic cancer	0.00407	0.0139	CbGbCtD
Acebutolol—ABCB1—Etoposide—hematologic cancer	0.004	0.0136	CbGbCtD
Acebutolol—ABCB1—Dexamethasone—hematologic cancer	0.00329	0.0112	CbGbCtD
Acebutolol—CYP2D6—Dexamethasone—hematologic cancer	0.0031	0.0106	CbGbCtD
Acebutolol—ABCB1—Doxorubicin—hematologic cancer	0.00273	0.00929	CbGbCtD
Acebutolol—ABCB1—Methotrexate—hematologic cancer	0.00264	0.009	CbGbCtD
Acebutolol—CYP2D6—Doxorubicin—hematologic cancer	0.00257	0.00876	CbGbCtD
Acebutolol—Rhinitis—Doxorubicin—hematologic cancer	2.14e-05	0.000143	CcSEcCtD
Acebutolol—Hypoaesthesia—Doxorubicin—hematologic cancer	2.13e-05	0.000142	CcSEcCtD
Acebutolol—Pharyngitis—Doxorubicin—hematologic cancer	2.12e-05	0.000141	CcSEcCtD
Acebutolol—Dyspepsia—Betamethasone—hematologic cancer	2.12e-05	0.000141	CcSEcCtD
Acebutolol—Dyspepsia—Dexamethasone—hematologic cancer	2.12e-05	0.000141	CcSEcCtD
Acebutolol—Urticaria—Triamcinolone—hematologic cancer	2.11e-05	0.000141	CcSEcCtD
Acebutolol—Asthenia—Etoposide—hematologic cancer	2.1e-05	0.00014	CcSEcCtD
Acebutolol—Connective tissue disorder—Doxorubicin—hematologic cancer	2.1e-05	0.00014	CcSEcCtD
Acebutolol—Body temperature increased—Triamcinolone—hematologic cancer	2.1e-05	0.00014	CcSEcCtD
Acebutolol—Oedema—Prednisone—hematologic cancer	2.1e-05	0.00014	CcSEcCtD
Acebutolol—Angiopathy—Epirubicin—hematologic cancer	2.1e-05	0.00014	CcSEcCtD
Acebutolol—Decreased appetite—Dexamethasone—hematologic cancer	2.1e-05	0.00014	CcSEcCtD
Acebutolol—Decreased appetite—Betamethasone—hematologic cancer	2.1e-05	0.00014	CcSEcCtD
Acebutolol—Nausea—Irinotecan—hematologic cancer	2.09e-05	0.000139	CcSEcCtD
Acebutolol—Nausea—Mitoxantrone—hematologic cancer	2.09e-05	0.000139	CcSEcCtD
Acebutolol—Mediastinal disorder—Epirubicin—hematologic cancer	2.08e-05	0.000139	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Betamethasone—hematologic cancer	2.08e-05	0.000139	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Dexamethasone—hematologic cancer	2.08e-05	0.000139	CcSEcCtD
Acebutolol—Back pain—Methotrexate—hematologic cancer	2.08e-05	0.000139	CcSEcCtD
Acebutolol—Fatigue—Dexamethasone—hematologic cancer	2.08e-05	0.000139	CcSEcCtD
Acebutolol—Fatigue—Betamethasone—hematologic cancer	2.08e-05	0.000139	CcSEcCtD
Acebutolol—Chills—Epirubicin—hematologic cancer	2.07e-05	0.000138	CcSEcCtD
Acebutolol—Pruritus—Etoposide—hematologic cancer	2.07e-05	0.000138	CcSEcCtD
Acebutolol—Shock—Prednisone—hematologic cancer	2.07e-05	0.000138	CcSEcCtD
Acebutolol—Pain—Dexamethasone—hematologic cancer	2.06e-05	0.000137	CcSEcCtD
Acebutolol—Pain—Betamethasone—hematologic cancer	2.06e-05	0.000137	CcSEcCtD
Acebutolol—Visual impairment—Doxorubicin—hematologic cancer	2.06e-05	0.000137	CcSEcCtD
Acebutolol—Nervous system disorder—Prednisone—hematologic cancer	2.06e-05	0.000137	CcSEcCtD
Acebutolol—Alopecia—Epirubicin—hematologic cancer	2.04e-05	0.000136	CcSEcCtD
Acebutolol—Skin disorder—Prednisone—hematologic cancer	2.04e-05	0.000136	CcSEcCtD
Acebutolol—Nausea—Gemcitabine—hematologic cancer	2.04e-05	0.000136	CcSEcCtD
Acebutolol—Vomiting—Cisplatin—hematologic cancer	2.03e-05	0.000136	CcSEcCtD
Acebutolol—Hyperhidrosis—Prednisone—hematologic cancer	2.03e-05	0.000135	CcSEcCtD
Acebutolol—Vision blurred—Methotrexate—hematologic cancer	2.03e-05	0.000135	CcSEcCtD
Acebutolol—Rash—Cisplatin—hematologic cancer	2.02e-05	0.000134	CcSEcCtD
Acebutolol—Dermatitis—Cisplatin—hematologic cancer	2.01e-05	0.000134	CcSEcCtD
Acebutolol—Diarrhoea—Etoposide—hematologic cancer	2e-05	0.000134	CcSEcCtD
Acebutolol—Anorexia—Prednisone—hematologic cancer	2e-05	0.000133	CcSEcCtD
Acebutolol—Ill-defined disorder—Methotrexate—hematologic cancer	1.99e-05	0.000133	CcSEcCtD
Acebutolol—Tinnitus—Doxorubicin—hematologic cancer	1.99e-05	0.000133	CcSEcCtD
Acebutolol—Feeling abnormal—Betamethasone—hematologic cancer	1.99e-05	0.000132	CcSEcCtD
Acebutolol—Feeling abnormal—Dexamethasone—hematologic cancer	1.99e-05	0.000132	CcSEcCtD
Acebutolol—Flushing—Doxorubicin—hematologic cancer	1.98e-05	0.000132	CcSEcCtD
Acebutolol—Flatulence—Epirubicin—hematologic cancer	1.98e-05	0.000132	CcSEcCtD
Acebutolol—Gastrointestinal pain—Betamethasone—hematologic cancer	1.97e-05	0.000131	CcSEcCtD
Acebutolol—Gastrointestinal pain—Dexamethasone—hematologic cancer	1.97e-05	0.000131	CcSEcCtD
Acebutolol—Back pain—Epirubicin—hematologic cancer	1.95e-05	0.00013	CcSEcCtD
Acebutolol—Angiopathy—Doxorubicin—hematologic cancer	1.94e-05	0.000129	CcSEcCtD
Acebutolol—Malaise—Methotrexate—hematologic cancer	1.94e-05	0.000129	CcSEcCtD
Acebutolol—Dizziness—Etoposide—hematologic cancer	1.94e-05	0.000129	CcSEcCtD
Acebutolol—Vertigo—Methotrexate—hematologic cancer	1.93e-05	0.000129	CcSEcCtD
Acebutolol—Mediastinal disorder—Doxorubicin—hematologic cancer	1.93e-05	0.000128	CcSEcCtD
Acebutolol—Chills—Doxorubicin—hematologic cancer	1.92e-05	0.000128	CcSEcCtD
Acebutolol—Urticaria—Dexamethasone—hematologic cancer	1.91e-05	0.000128	CcSEcCtD
Acebutolol—Urticaria—Betamethasone—hematologic cancer	1.91e-05	0.000128	CcSEcCtD
Acebutolol—Musculoskeletal discomfort—Prednisone—hematologic cancer	1.91e-05	0.000128	CcSEcCtD
Acebutolol—Dizziness—Prednisolone—hematologic cancer	1.91e-05	0.000127	CcSEcCtD
Acebutolol—Asthenia—Triamcinolone—hematologic cancer	1.91e-05	0.000127	CcSEcCtD
Acebutolol—Body temperature increased—Dexamethasone—hematologic cancer	1.91e-05	0.000127	CcSEcCtD
Acebutolol—Body temperature increased—Betamethasone—hematologic cancer	1.91e-05	0.000127	CcSEcCtD
Acebutolol—Abdominal pain—Dexamethasone—hematologic cancer	1.91e-05	0.000127	CcSEcCtD
Acebutolol—Abdominal pain—Betamethasone—hematologic cancer	1.91e-05	0.000127	CcSEcCtD
Acebutolol—Nausea—Cisplatin—hematologic cancer	1.9e-05	0.000127	CcSEcCtD
Acebutolol—Insomnia—Prednisone—hematologic cancer	1.9e-05	0.000127	CcSEcCtD
Acebutolol—Vision blurred—Epirubicin—hematologic cancer	1.9e-05	0.000126	CcSEcCtD
Acebutolol—Alopecia—Doxorubicin—hematologic cancer	1.89e-05	0.000126	CcSEcCtD
Acebutolol—Paraesthesia—Prednisone—hematologic cancer	1.89e-05	0.000126	CcSEcCtD
Acebutolol—Pruritus—Triamcinolone—hematologic cancer	1.88e-05	0.000125	CcSEcCtD
Acebutolol—Cough—Methotrexate—hematologic cancer	1.88e-05	0.000125	CcSEcCtD
Acebutolol—Ill-defined disorder—Epirubicin—hematologic cancer	1.87e-05	0.000124	CcSEcCtD
Acebutolol—Vomiting—Etoposide—hematologic cancer	1.86e-05	0.000124	CcSEcCtD
Acebutolol—Dyspepsia—Prednisone—hematologic cancer	1.85e-05	0.000123	CcSEcCtD
Acebutolol—Rash—Etoposide—hematologic cancer	1.85e-05	0.000123	CcSEcCtD
Acebutolol—Dermatitis—Etoposide—hematologic cancer	1.85e-05	0.000123	CcSEcCtD
Acebutolol—Headache—Etoposide—hematologic cancer	1.83e-05	0.000122	CcSEcCtD
Acebutolol—Flatulence—Doxorubicin—hematologic cancer	1.83e-05	0.000122	CcSEcCtD
Acebutolol—Myalgia—Methotrexate—hematologic cancer	1.83e-05	0.000122	CcSEcCtD
Acebutolol—Arthralgia—Methotrexate—hematologic cancer	1.83e-05	0.000122	CcSEcCtD
Acebutolol—Chest pain—Methotrexate—hematologic cancer	1.83e-05	0.000122	CcSEcCtD
Acebutolol—Decreased appetite—Prednisone—hematologic cancer	1.82e-05	0.000122	CcSEcCtD
Acebutolol—Rash—Prednisolone—hematologic cancer	1.82e-05	0.000121	CcSEcCtD
Acebutolol—Dermatitis—Prednisolone—hematologic cancer	1.82e-05	0.000121	CcSEcCtD
Acebutolol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	1.82e-05	0.000121	CcSEcCtD
Acebutolol—Malaise—Epirubicin—hematologic cancer	1.81e-05	0.000121	CcSEcCtD
Acebutolol—Fatigue—Prednisone—hematologic cancer	1.81e-05	0.000121	CcSEcCtD
Acebutolol—Headache—Prednisolone—hematologic cancer	1.81e-05	0.000121	CcSEcCtD
Acebutolol—Discomfort—Methotrexate—hematologic cancer	1.81e-05	0.000121	CcSEcCtD
Acebutolol—Vertigo—Epirubicin—hematologic cancer	1.81e-05	0.000121	CcSEcCtD
Acebutolol—Syncope—Epirubicin—hematologic cancer	1.8e-05	0.00012	CcSEcCtD
Acebutolol—Back pain—Doxorubicin—hematologic cancer	1.8e-05	0.00012	CcSEcCtD
Acebutolol—Constipation—Prednisone—hematologic cancer	1.8e-05	0.00012	CcSEcCtD
Acebutolol—Palpitations—Epirubicin—hematologic cancer	1.78e-05	0.000119	CcSEcCtD
Acebutolol—Confusional state—Methotrexate—hematologic cancer	1.77e-05	0.000118	CcSEcCtD
Acebutolol—Loss of consciousness—Epirubicin—hematologic cancer	1.77e-05	0.000118	CcSEcCtD
Acebutolol—Dizziness—Triamcinolone—hematologic cancer	1.76e-05	0.000117	CcSEcCtD
Acebutolol—Cough—Epirubicin—hematologic cancer	1.76e-05	0.000117	CcSEcCtD
Acebutolol—Vision blurred—Doxorubicin—hematologic cancer	1.75e-05	0.000117	CcSEcCtD
Acebutolol—Nausea—Etoposide—hematologic cancer	1.74e-05	0.000116	CcSEcCtD
Acebutolol—Feeling abnormal—Prednisone—hematologic cancer	1.73e-05	0.000115	CcSEcCtD
Acebutolol—Asthenia—Dexamethasone—hematologic cancer	1.73e-05	0.000115	CcSEcCtD
Acebutolol—Asthenia—Betamethasone—hematologic cancer	1.73e-05	0.000115	CcSEcCtD
Acebutolol—Ill-defined disorder—Doxorubicin—hematologic cancer	1.73e-05	0.000115	CcSEcCtD
Acebutolol—Nervous system disorder—Methotrexate—hematologic cancer	1.72e-05	0.000115	CcSEcCtD
Acebutolol—Gastrointestinal pain—Prednisone—hematologic cancer	1.72e-05	0.000114	CcSEcCtD
Acebutolol—Nausea—Prednisolone—hematologic cancer	1.72e-05	0.000114	CcSEcCtD
Acebutolol—Chest pain—Epirubicin—hematologic cancer	1.71e-05	0.000114	CcSEcCtD
Acebutolol—Myalgia—Epirubicin—hematologic cancer	1.71e-05	0.000114	CcSEcCtD
Acebutolol—Arthralgia—Epirubicin—hematologic cancer	1.71e-05	0.000114	CcSEcCtD
Acebutolol—Anxiety—Epirubicin—hematologic cancer	1.71e-05	0.000114	CcSEcCtD
Acebutolol—Pruritus—Betamethasone—hematologic cancer	1.71e-05	0.000114	CcSEcCtD
Acebutolol—Pruritus—Dexamethasone—hematologic cancer	1.71e-05	0.000114	CcSEcCtD
Acebutolol—Skin disorder—Methotrexate—hematologic cancer	1.7e-05	0.000114	CcSEcCtD
Acebutolol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	1.7e-05	0.000113	CcSEcCtD
Acebutolol—Hyperhidrosis—Methotrexate—hematologic cancer	1.7e-05	0.000113	CcSEcCtD
Acebutolol—Discomfort—Epirubicin—hematologic cancer	1.69e-05	0.000113	CcSEcCtD
Acebutolol—Vomiting—Triamcinolone—hematologic cancer	1.69e-05	0.000113	CcSEcCtD
Acebutolol—Malaise—Doxorubicin—hematologic cancer	1.68e-05	0.000112	CcSEcCtD
Acebutolol—Rash—Triamcinolone—hematologic cancer	1.68e-05	0.000112	CcSEcCtD
Acebutolol—Dermatitis—Triamcinolone—hematologic cancer	1.67e-05	0.000112	CcSEcCtD
Acebutolol—Vertigo—Doxorubicin—hematologic cancer	1.67e-05	0.000111	CcSEcCtD
Acebutolol—Anorexia—Methotrexate—hematologic cancer	1.67e-05	0.000111	CcSEcCtD
Acebutolol—Syncope—Doxorubicin—hematologic cancer	1.67e-05	0.000111	CcSEcCtD
Acebutolol—Urticaria—Prednisone—hematologic cancer	1.67e-05	0.000111	CcSEcCtD
Acebutolol—Headache—Triamcinolone—hematologic cancer	1.66e-05	0.000111	CcSEcCtD
Acebutolol—Abdominal pain—Prednisone—hematologic cancer	1.66e-05	0.000111	CcSEcCtD
Acebutolol—Body temperature increased—Prednisone—hematologic cancer	1.66e-05	0.000111	CcSEcCtD
Acebutolol—Confusional state—Epirubicin—hematologic cancer	1.66e-05	0.00011	CcSEcCtD
Acebutolol—Diarrhoea—Dexamethasone—hematologic cancer	1.65e-05	0.00011	CcSEcCtD
Acebutolol—Diarrhoea—Betamethasone—hematologic cancer	1.65e-05	0.00011	CcSEcCtD
Acebutolol—Palpitations—Doxorubicin—hematologic cancer	1.64e-05	0.00011	CcSEcCtD
Acebutolol—Oedema—Epirubicin—hematologic cancer	1.64e-05	0.000109	CcSEcCtD
Acebutolol—Hypotension—Methotrexate—hematologic cancer	1.64e-05	0.000109	CcSEcCtD
Acebutolol—Loss of consciousness—Doxorubicin—hematologic cancer	1.64e-05	0.000109	CcSEcCtD
Acebutolol—Cough—Doxorubicin—hematologic cancer	1.62e-05	0.000108	CcSEcCtD
Acebutolol—Shock—Epirubicin—hematologic cancer	1.62e-05	0.000108	CcSEcCtD
Acebutolol—Nervous system disorder—Epirubicin—hematologic cancer	1.61e-05	0.000107	CcSEcCtD
Acebutolol—Musculoskeletal discomfort—Methotrexate—hematologic cancer	1.6e-05	0.000107	CcSEcCtD
Acebutolol—Skin disorder—Epirubicin—hematologic cancer	1.59e-05	0.000106	CcSEcCtD
Acebutolol—Dizziness—Dexamethasone—hematologic cancer	1.59e-05	0.000106	CcSEcCtD
Acebutolol—Dizziness—Betamethasone—hematologic cancer	1.59e-05	0.000106	CcSEcCtD
Acebutolol—Hyperhidrosis—Epirubicin—hematologic cancer	1.59e-05	0.000106	CcSEcCtD
Acebutolol—Insomnia—Methotrexate—hematologic cancer	1.59e-05	0.000106	CcSEcCtD
Acebutolol—Myalgia—Doxorubicin—hematologic cancer	1.58e-05	0.000106	CcSEcCtD
Acebutolol—Chest pain—Doxorubicin—hematologic cancer	1.58e-05	0.000106	CcSEcCtD
Acebutolol—Arthralgia—Doxorubicin—hematologic cancer	1.58e-05	0.000106	CcSEcCtD
Acebutolol—Anxiety—Doxorubicin—hematologic cancer	1.58e-05	0.000105	CcSEcCtD
Acebutolol—Nausea—Triamcinolone—hematologic cancer	1.58e-05	0.000105	CcSEcCtD
Acebutolol—Paraesthesia—Methotrexate—hematologic cancer	1.58e-05	0.000105	CcSEcCtD
Acebutolol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	1.57e-05	0.000105	CcSEcCtD
Acebutolol—Discomfort—Doxorubicin—hematologic cancer	1.57e-05	0.000104	CcSEcCtD
Acebutolol—Anorexia—Epirubicin—hematologic cancer	1.57e-05	0.000104	CcSEcCtD
Acebutolol—Dyspnoea—Methotrexate—hematologic cancer	1.56e-05	0.000104	CcSEcCtD
Acebutolol—Somnolence—Methotrexate—hematologic cancer	1.56e-05	0.000104	CcSEcCtD
Acebutolol—Dyspepsia—Methotrexate—hematologic cancer	1.54e-05	0.000103	CcSEcCtD
Acebutolol—Hypotension—Epirubicin—hematologic cancer	1.53e-05	0.000102	CcSEcCtD
Acebutolol—Vomiting—Betamethasone—hematologic cancer	1.53e-05	0.000102	CcSEcCtD
Acebutolol—Vomiting—Dexamethasone—hematologic cancer	1.53e-05	0.000102	CcSEcCtD
Acebutolol—Confusional state—Doxorubicin—hematologic cancer	1.53e-05	0.000102	CcSEcCtD
Acebutolol—Decreased appetite—Methotrexate—hematologic cancer	1.53e-05	0.000102	CcSEcCtD
Acebutolol—Rash—Dexamethasone—hematologic cancer	1.52e-05	0.000101	CcSEcCtD
Acebutolol—Rash—Betamethasone—hematologic cancer	1.52e-05	0.000101	CcSEcCtD
Acebutolol—Oedema—Doxorubicin—hematologic cancer	1.52e-05	0.000101	CcSEcCtD
Acebutolol—Dermatitis—Dexamethasone—hematologic cancer	1.52e-05	0.000101	CcSEcCtD
Acebutolol—Dermatitis—Betamethasone—hematologic cancer	1.52e-05	0.000101	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Methotrexate—hematologic cancer	1.51e-05	0.000101	CcSEcCtD
Acebutolol—Fatigue—Methotrexate—hematologic cancer	1.51e-05	0.000101	CcSEcCtD
Acebutolol—Headache—Betamethasone—hematologic cancer	1.51e-05	0.000101	CcSEcCtD
Acebutolol—Headache—Dexamethasone—hematologic cancer	1.51e-05	0.000101	CcSEcCtD
Acebutolol—Asthenia—Prednisone—hematologic cancer	1.51e-05	0.0001	CcSEcCtD
Acebutolol—Pain—Methotrexate—hematologic cancer	1.5e-05	0.0001	CcSEcCtD
Acebutolol—Musculoskeletal discomfort—Epirubicin—hematologic cancer	1.5e-05	9.97e-05	CcSEcCtD
Acebutolol—Shock—Doxorubicin—hematologic cancer	1.49e-05	9.96e-05	CcSEcCtD
Acebutolol—Nervous system disorder—Doxorubicin—hematologic cancer	1.49e-05	9.93e-05	CcSEcCtD
Acebutolol—Pruritus—Prednisone—hematologic cancer	1.49e-05	9.9e-05	CcSEcCtD
Acebutolol—Insomnia—Epirubicin—hematologic cancer	1.48e-05	9.9e-05	CcSEcCtD
Acebutolol—Skin disorder—Doxorubicin—hematologic cancer	1.48e-05	9.84e-05	CcSEcCtD
Acebutolol—Paraesthesia—Epirubicin—hematologic cancer	1.47e-05	9.83e-05	CcSEcCtD
Acebutolol—Hyperhidrosis—Doxorubicin—hematologic cancer	1.47e-05	9.79e-05	CcSEcCtD
Acebutolol—Dyspnoea—Epirubicin—hematologic cancer	1.46e-05	9.76e-05	CcSEcCtD
Acebutolol—Somnolence—Epirubicin—hematologic cancer	1.46e-05	9.73e-05	CcSEcCtD
Acebutolol—Anorexia—Doxorubicin—hematologic cancer	1.45e-05	9.65e-05	CcSEcCtD
Acebutolol—Feeling abnormal—Methotrexate—hematologic cancer	1.45e-05	9.64e-05	CcSEcCtD
Acebutolol—Dyspepsia—Epirubicin—hematologic cancer	1.45e-05	9.64e-05	CcSEcCtD
Acebutolol—Diarrhoea—Prednisone—hematologic cancer	1.44e-05	9.58e-05	CcSEcCtD
Acebutolol—Gastrointestinal pain—Methotrexate—hematologic cancer	1.43e-05	9.56e-05	CcSEcCtD
Acebutolol—Nausea—Dexamethasone—hematologic cancer	1.43e-05	9.55e-05	CcSEcCtD
Acebutolol—Nausea—Betamethasone—hematologic cancer	1.43e-05	9.55e-05	CcSEcCtD
Acebutolol—Decreased appetite—Epirubicin—hematologic cancer	1.43e-05	9.52e-05	CcSEcCtD
Acebutolol—Hypotension—Doxorubicin—hematologic cancer	1.42e-05	9.46e-05	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Epirubicin—hematologic cancer	1.42e-05	9.45e-05	CcSEcCtD
Acebutolol—Fatigue—Epirubicin—hematologic cancer	1.42e-05	9.44e-05	CcSEcCtD
Acebutolol—Constipation—Epirubicin—hematologic cancer	1.4e-05	9.36e-05	CcSEcCtD
Acebutolol—Pain—Epirubicin—hematologic cancer	1.4e-05	9.36e-05	CcSEcCtD
Acebutolol—Urticaria—Methotrexate—hematologic cancer	1.39e-05	9.29e-05	CcSEcCtD
Acebutolol—Dizziness—Prednisone—hematologic cancer	1.39e-05	9.26e-05	CcSEcCtD
Acebutolol—Body temperature increased—Methotrexate—hematologic cancer	1.39e-05	9.25e-05	CcSEcCtD
Acebutolol—Abdominal pain—Methotrexate—hematologic cancer	1.39e-05	9.25e-05	CcSEcCtD
Acebutolol—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	1.38e-05	9.23e-05	CcSEcCtD
Acebutolol—Insomnia—Doxorubicin—hematologic cancer	1.37e-05	9.16e-05	CcSEcCtD
Acebutolol—Paraesthesia—Doxorubicin—hematologic cancer	1.36e-05	9.09e-05	CcSEcCtD
Acebutolol—Dyspnoea—Doxorubicin—hematologic cancer	1.35e-05	9.03e-05	CcSEcCtD
Acebutolol—Feeling abnormal—Epirubicin—hematologic cancer	1.35e-05	9.02e-05	CcSEcCtD
Acebutolol—Somnolence—Doxorubicin—hematologic cancer	1.35e-05	9e-05	CcSEcCtD
Acebutolol—Gastrointestinal pain—Epirubicin—hematologic cancer	1.34e-05	8.95e-05	CcSEcCtD
Acebutolol—Dyspepsia—Doxorubicin—hematologic cancer	1.34e-05	8.92e-05	CcSEcCtD
Acebutolol—Vomiting—Prednisone—hematologic cancer	1.33e-05	8.9e-05	CcSEcCtD
Acebutolol—Rash—Prednisone—hematologic cancer	1.32e-05	8.82e-05	CcSEcCtD
Acebutolol—Dermatitis—Prednisone—hematologic cancer	1.32e-05	8.82e-05	CcSEcCtD
Acebutolol—Decreased appetite—Doxorubicin—hematologic cancer	1.32e-05	8.8e-05	CcSEcCtD
Acebutolol—Headache—Prednisone—hematologic cancer	1.32e-05	8.77e-05	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Doxorubicin—hematologic cancer	1.31e-05	8.74e-05	CcSEcCtD
Acebutolol—Fatigue—Doxorubicin—hematologic cancer	1.31e-05	8.73e-05	CcSEcCtD
Acebutolol—Urticaria—Epirubicin—hematologic cancer	1.3e-05	8.7e-05	CcSEcCtD
Acebutolol—Constipation—Doxorubicin—hematologic cancer	1.3e-05	8.66e-05	CcSEcCtD
Acebutolol—Pain—Doxorubicin—hematologic cancer	1.3e-05	8.66e-05	CcSEcCtD
Acebutolol—Abdominal pain—Epirubicin—hematologic cancer	1.3e-05	8.65e-05	CcSEcCtD
Acebutolol—Body temperature increased—Epirubicin—hematologic cancer	1.3e-05	8.65e-05	CcSEcCtD
Acebutolol—Asthenia—Methotrexate—hematologic cancer	1.26e-05	8.39e-05	CcSEcCtD
Acebutolol—Feeling abnormal—Doxorubicin—hematologic cancer	1.25e-05	8.35e-05	CcSEcCtD
Acebutolol—Nausea—Prednisone—hematologic cancer	1.25e-05	8.31e-05	CcSEcCtD
Acebutolol—Gastrointestinal pain—Doxorubicin—hematologic cancer	1.24e-05	8.28e-05	CcSEcCtD
Acebutolol—Pruritus—Methotrexate—hematologic cancer	1.24e-05	8.28e-05	CcSEcCtD
Acebutolol—Urticaria—Doxorubicin—hematologic cancer	1.21e-05	8.05e-05	CcSEcCtD
Acebutolol—Body temperature increased—Doxorubicin—hematologic cancer	1.2e-05	8.01e-05	CcSEcCtD
Acebutolol—Abdominal pain—Doxorubicin—hematologic cancer	1.2e-05	8.01e-05	CcSEcCtD
Acebutolol—Diarrhoea—Methotrexate—hematologic cancer	1.2e-05	8e-05	CcSEcCtD
Acebutolol—Asthenia—Epirubicin—hematologic cancer	1.18e-05	7.85e-05	CcSEcCtD
Acebutolol—Pruritus—Epirubicin—hematologic cancer	1.16e-05	7.74e-05	CcSEcCtD
Acebutolol—Dizziness—Methotrexate—hematologic cancer	1.16e-05	7.73e-05	CcSEcCtD
Acebutolol—Diarrhoea—Epirubicin—hematologic cancer	1.12e-05	7.49e-05	CcSEcCtD
Acebutolol—Vomiting—Methotrexate—hematologic cancer	1.12e-05	7.44e-05	CcSEcCtD
Acebutolol—Rash—Methotrexate—hematologic cancer	1.11e-05	7.38e-05	CcSEcCtD
Acebutolol—Dermatitis—Methotrexate—hematologic cancer	1.11e-05	7.37e-05	CcSEcCtD
Acebutolol—Headache—Methotrexate—hematologic cancer	1.1e-05	7.33e-05	CcSEcCtD
Acebutolol—Asthenia—Doxorubicin—hematologic cancer	1.09e-05	7.27e-05	CcSEcCtD
Acebutolol—Dizziness—Epirubicin—hematologic cancer	1.09e-05	7.24e-05	CcSEcCtD
Acebutolol—Pruritus—Doxorubicin—hematologic cancer	1.07e-05	7.17e-05	CcSEcCtD
Acebutolol—Vomiting—Epirubicin—hematologic cancer	1.04e-05	6.96e-05	CcSEcCtD
Acebutolol—Nausea—Methotrexate—hematologic cancer	1.04e-05	6.95e-05	CcSEcCtD
Acebutolol—Diarrhoea—Doxorubicin—hematologic cancer	1.04e-05	6.93e-05	CcSEcCtD
Acebutolol—Rash—Epirubicin—hematologic cancer	1.04e-05	6.9e-05	CcSEcCtD
Acebutolol—Dermatitis—Epirubicin—hematologic cancer	1.03e-05	6.9e-05	CcSEcCtD
Acebutolol—Headache—Epirubicin—hematologic cancer	1.03e-05	6.86e-05	CcSEcCtD
Acebutolol—Dizziness—Doxorubicin—hematologic cancer	1e-05	6.7e-05	CcSEcCtD
Acebutolol—Nausea—Epirubicin—hematologic cancer	9.75e-06	6.5e-05	CcSEcCtD
Acebutolol—Vomiting—Doxorubicin—hematologic cancer	9.66e-06	6.44e-05	CcSEcCtD
Acebutolol—Rash—Doxorubicin—hematologic cancer	9.58e-06	6.39e-05	CcSEcCtD
Acebutolol—Dermatitis—Doxorubicin—hematologic cancer	9.57e-06	6.38e-05	CcSEcCtD
Acebutolol—Headache—Doxorubicin—hematologic cancer	9.52e-06	6.35e-05	CcSEcCtD
Acebutolol—Nausea—Doxorubicin—hematologic cancer	9.02e-06	6.02e-05	CcSEcCtD
Acebutolol—ABCB1—Metabolism—SLC22A1—hematologic cancer	5.21e-06	0.000188	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—CRABP1—hematologic cancer	5.21e-06	0.000188	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—PIK3R1—hematologic cancer	5.2e-06	0.000188	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—CCL2—hematologic cancer	5.18e-06	0.000187	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—IL6R—hematologic cancer	5.17e-06	0.000187	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—PIK3R1—hematologic cancer	5.09e-06	0.000184	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—ALOX5—hematologic cancer	5.08e-06	0.000184	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	5.08e-06	0.000184	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—JAK2—hematologic cancer	5.05e-06	0.000183	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—UGT1A1—hematologic cancer	5.05e-06	0.000183	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—MAP2K1—hematologic cancer	5.03e-06	0.000182	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—GRB2—hematologic cancer	5.01e-06	0.000181	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—PIK3CD—hematologic cancer	5e-06	0.000181	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—PDGFA—hematologic cancer	5e-06	0.000181	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—ABCB1—hematologic cancer	4.94e-06	0.000179	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—JAK2—hematologic cancer	4.94e-06	0.000179	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—KITLG—hematologic cancer	4.92e-06	0.000178	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—MAP2K1—hematologic cancer	4.92e-06	0.000178	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—NUP98—hematologic cancer	4.92e-06	0.000178	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—SLC22A1—hematologic cancer	4.91e-06	0.000178	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—CRABP1—hematologic cancer	4.91e-06	0.000178	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—GRB2—hematologic cancer	4.9e-06	0.000177	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—PIK3CD—hematologic cancer	4.89e-06	0.000177	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—PDGFA—hematologic cancer	4.89e-06	0.000177	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—KITLG—hematologic cancer	4.82e-06	0.000174	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—STAT5A—hematologic cancer	4.81e-06	0.000174	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—NCOR1—hematologic cancer	4.8e-06	0.000174	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—GSTM1—hematologic cancer	4.8e-06	0.000174	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—PIK3CB—hematologic cancer	4.8e-06	0.000174	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—ALOX5—hematologic cancer	4.78e-06	0.000173	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—ADCY7—hematologic cancer	4.77e-06	0.000173	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—NCOA3—hematologic cancer	4.77e-06	0.000173	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CDKN2B—hematologic cancer	4.77e-06	0.000173	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—NUP214—hematologic cancer	4.74e-06	0.000171	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—PIK3R1—hematologic cancer	4.72e-06	0.000171	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—STAT5A—hematologic cancer	4.71e-06	0.00017	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—PIK3CB—hematologic cancer	4.69e-06	0.00017	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CDKN2B—hematologic cancer	4.67e-06	0.000169	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—ABCG2—hematologic cancer	4.64e-06	0.000168	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—MTR—hematologic cancer	4.64e-06	0.000168	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—NUP98—hematologic cancer	4.63e-06	0.000168	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—PIK3R1—hematologic cancer	4.62e-06	0.000167	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CD86—hematologic cancer	4.61e-06	0.000167	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—JAK2—hematologic cancer	4.59e-06	0.000166	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—ENO2—hematologic cancer	4.55e-06	0.000165	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—HES1—hematologic cancer	4.55e-06	0.000165	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—NCOR1—hematologic cancer	4.52e-06	0.000164	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CD86—hematologic cancer	4.51e-06	0.000163	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—ADCY7—hematologic cancer	4.5e-06	0.000163	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—NCOA3—hematologic cancer	4.5e-06	0.000163	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—JAK2—hematologic cancer	4.49e-06	0.000162	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CSF2—hematologic cancer	4.47e-06	0.000162	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—FGF1—hematologic cancer	4.47e-06	0.000162	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—NUP214—hematologic cancer	4.47e-06	0.000162	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—HES1—hematologic cancer	4.45e-06	0.000161	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—NCOR1—hematologic cancer	4.43e-06	0.00016	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—GSTT1—hematologic cancer	4.42e-06	0.00016	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—FOXO1—hematologic cancer	4.41e-06	0.00016	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—IL2—hematologic cancer	4.41e-06	0.000159	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—PDGFRB—hematologic cancer	4.4e-06	0.000159	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—FGF1—hematologic cancer	4.38e-06	0.000158	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CSF2—hematologic cancer	4.38e-06	0.000158	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—ABCG2—hematologic cancer	4.38e-06	0.000158	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—MTR—hematologic cancer	4.38e-06	0.000158	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—PIK3CB—hematologic cancer	4.36e-06	0.000158	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—PDGFRA—hematologic cancer	4.33e-06	0.000157	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—JAK1—hematologic cancer	4.32e-06	0.000156	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—PRKCG—hematologic cancer	4.32e-06	0.000156	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—SDC1—hematologic cancer	4.32e-06	0.000156	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—FOXO1—hematologic cancer	4.31e-06	0.000156	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—IL2—hematologic cancer	4.31e-06	0.000156	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—PDGFRB—hematologic cancer	4.31e-06	0.000156	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—ENO2—hematologic cancer	4.29e-06	0.000155	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	4.29e-06	0.000155	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—PIK3CB—hematologic cancer	4.26e-06	0.000154	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—MTHFR—hematologic cancer	4.24e-06	0.000153	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—PDGFRA—hematologic cancer	4.24e-06	0.000153	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—JAK1—hematologic cancer	4.22e-06	0.000153	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—PRKCG—hematologic cancer	4.22e-06	0.000153	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—GSTT1—hematologic cancer	4.16e-06	0.000151	CbGpPWpGaD
Acebutolol—ABCB1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	4.13e-06	0.00015	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—SDC1—hematologic cancer	4.07e-06	0.000147	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—IL2RA—hematologic cancer	4.03e-06	0.000146	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—IL2—hematologic cancer	4e-06	0.000145	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—TERT—hematologic cancer	3.99e-06	0.000144	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—IL2RA—hematologic cancer	3.94e-06	0.000143	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—IL2—hematologic cancer	3.92e-06	0.000142	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—TERT—hematologic cancer	3.9e-06	0.000141	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—PDGFB—hematologic cancer	3.89e-06	0.000141	CbGpPWpGaD
Acebutolol—ABCB1—Transmembrane transport of small molecules—ALB—hematologic cancer	3.87e-06	0.00014	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—PDGFB—hematologic cancer	3.81e-06	0.000138	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—TSC2—hematologic cancer	3.8e-06	0.000138	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—TSC2—hematologic cancer	3.72e-06	0.000135	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—NQO1—hematologic cancer	3.67e-06	0.000133	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—CD44—hematologic cancer	3.67e-06	0.000133	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—FGFR3—hematologic cancer	3.66e-06	0.000132	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—MAPK14—hematologic cancer	3.62e-06	0.000131	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—FGFR3—hematologic cancer	3.58e-06	0.000129	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—PIK3CG—hematologic cancer	3.56e-06	0.000129	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—ESR1—hematologic cancer	3.55e-06	0.000129	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—MAPK14—hematologic cancer	3.54e-06	0.000128	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—FN1—hematologic cancer	3.51e-06	0.000127	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—ESR1—hematologic cancer	3.48e-06	0.000126	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—CYCS—hematologic cancer	3.47e-06	0.000126	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—BAD—hematologic cancer	3.47e-06	0.000125	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—NFKBIA—hematologic cancer	3.47e-06	0.000125	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—CD44—hematologic cancer	3.46e-06	0.000125	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—NQO1—hematologic cancer	3.46e-06	0.000125	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—HSP90AA1—hematologic cancer	3.45e-06	0.000125	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—NOTCH1—hematologic cancer	3.44e-06	0.000124	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—FN1—hematologic cancer	3.43e-06	0.000124	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—NFKBIA—hematologic cancer	3.39e-06	0.000123	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—BAD—hematologic cancer	3.39e-06	0.000123	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CD80—hematologic cancer	3.37e-06	0.000122	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—NOTCH1—hematologic cancer	3.36e-06	0.000122	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—PIK3CG—hematologic cancer	3.36e-06	0.000122	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—KIT—hematologic cancer	3.36e-06	0.000122	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—NRAS—hematologic cancer	3.36e-06	0.000122	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—CREBBP—hematologic cancer	3.3e-06	0.00012	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—PTPN11—hematologic cancer	3.3e-06	0.000119	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CD80—hematologic cancer	3.29e-06	0.000119	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—PIK3CG—hematologic cancer	3.29e-06	0.000119	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—KIT—hematologic cancer	3.29e-06	0.000119	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—NRAS—hematologic cancer	3.29e-06	0.000119	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—CYCS—hematologic cancer	3.27e-06	0.000118	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—HSP90AA1—hematologic cancer	3.25e-06	0.000118	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—PTPN11—hematologic cancer	3.23e-06	0.000117	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—MAPK3—hematologic cancer	3.22e-06	0.000116	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CREB1—hematologic cancer	3.2e-06	0.000116	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—BRAF—hematologic cancer	3.16e-06	0.000114	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—MAPK3—hematologic cancer	3.15e-06	0.000114	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—PIK3CD—hematologic cancer	3.13e-06	0.000113	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CCL2—hematologic cancer	3.13e-06	0.000113	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CREB1—hematologic cancer	3.13e-06	0.000113	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—IL6R—hematologic cancer	3.12e-06	0.000113	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CREBBP—hematologic cancer	3.11e-06	0.000113	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—ALB—hematologic cancer	3.09e-06	0.000112	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—BRAF—hematologic cancer	3.09e-06	0.000112	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—GSTP1—hematologic cancer	3.06e-06	0.000111	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CCL2—hematologic cancer	3.06e-06	0.000111	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—IL6R—hematologic cancer	3.05e-06	0.00011	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CREBBP—hematologic cancer	3.05e-06	0.00011	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—MAP2K1—hematologic cancer	2.97e-06	0.000108	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—PIK3R1—hematologic cancer	2.96e-06	0.000107	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—PIK3CD—hematologic cancer	2.95e-06	0.000107	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—PIK3CA—hematologic cancer	2.93e-06	0.000106	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—MAP2K1—hematologic cancer	2.91e-06	0.000105	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—KRAS—hematologic cancer	2.89e-06	0.000105	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—PIK3CD—hematologic cancer	2.89e-06	0.000105	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—GSTP1—hematologic cancer	2.88e-06	0.000104	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—PIK3CA—hematologic cancer	2.86e-06	0.000104	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—KRAS—hematologic cancer	2.83e-06	0.000102	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—FGF2—hematologic cancer	2.83e-06	0.000102	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—NCOR1—hematologic cancer	2.81e-06	0.000102	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—GSTM1—hematologic cancer	2.81e-06	0.000102	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—PIK3R1—hematologic cancer	2.79e-06	0.000101	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—FGF2—hematologic cancer	2.77e-06	0.0001	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—PIK3CB—hematologic cancer	2.73e-06	9.88e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—ABCB1—hematologic cancer	2.73e-06	9.88e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—PIK3R1—hematologic cancer	2.73e-06	9.87e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—JAK2—hematologic cancer	2.71e-06	9.81e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—PIK3CA—hematologic cancer	2.66e-06	9.61e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—JAK2—hematologic cancer	2.65e-06	9.59e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—GSTM1—hematologic cancer	2.65e-06	9.59e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—NCOR1—hematologic cancer	2.65e-06	9.59e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—MDM2—hematologic cancer	2.65e-06	9.57e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—PIK3CA—hematologic cancer	2.6e-06	9.4e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—MDM2—hematologic cancer	2.59e-06	9.36e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—PIK3CB—hematologic cancer	2.57e-06	9.31e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—MTOR—hematologic cancer	2.57e-06	9.31e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—MTOR—hematologic cancer	2.52e-06	9.11e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—PIK3CB—hematologic cancer	2.52e-06	9.11e-05	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—MTHFR—hematologic cancer	2.49e-06	8.99e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—HRAS—hematologic cancer	2.46e-06	8.89e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CDKN1B—hematologic cancer	2.42e-06	8.74e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—HRAS—hematologic cancer	2.4e-06	8.7e-05	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—AKT1—hematologic cancer	2.39e-06	8.65e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CASP3—hematologic cancer	2.37e-06	8.57e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—IL2—hematologic cancer	2.36e-06	8.55e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CDKN1B—hematologic cancer	2.36e-06	8.55e-05	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—PTEN—hematologic cancer	2.36e-06	8.54e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—IL6—hematologic cancer	2.35e-06	8.51e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—MTHFR—hematologic cancer	2.34e-06	8.48e-05	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—AKT1—hematologic cancer	2.34e-06	8.46e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CASP3—hematologic cancer	2.32e-06	8.38e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—IL2—hematologic cancer	2.31e-06	8.37e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CCND1—hematologic cancer	2.3e-06	8.34e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—IL6—hematologic cancer	2.3e-06	8.32e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—JUN—hematologic cancer	2.3e-06	8.32e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CCND1—hematologic cancer	2.25e-06	8.16e-05	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—EP300—hematologic cancer	2.25e-06	8.14e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—JUN—hematologic cancer	2.25e-06	8.14e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CDKN1A—hematologic cancer	2.23e-06	8.07e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—PTEN—hematologic cancer	2.22e-06	8.05e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CDKN1A—hematologic cancer	2.18e-06	7.89e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—MAPK8—hematologic cancer	2.18e-06	7.87e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—PTEN—hematologic cancer	2.18e-06	7.87e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—AKT1—hematologic cancer	2.17e-06	7.85e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—MAPK8—hematologic cancer	2.13e-06	7.7e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—AKT1—hematologic cancer	2.12e-06	7.68e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—EP300—hematologic cancer	2.12e-06	7.67e-05	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—PIK3CG—hematologic cancer	2.09e-06	7.56e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—EP300—hematologic cancer	2.08e-06	7.51e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—SRC—hematologic cancer	2.06e-06	7.46e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—SRC—hematologic cancer	2.02e-06	7.3e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—VEGFA—hematologic cancer	2.01e-06	7.27e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—STAT3—hematologic cancer	1.99e-06	7.2e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—NRAS—hematologic cancer	1.98e-06	7.18e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—PIK3CG—hematologic cancer	1.97e-06	7.12e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—VEGFA—hematologic cancer	1.97e-06	7.11e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—STAT3—hematologic cancer	1.95e-06	7.04e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—NRAS—hematologic cancer	1.94e-06	7.02e-05	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—CREBBP—hematologic cancer	1.94e-06	7.01e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—MAPK3—hematologic cancer	1.9e-06	6.88e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—MAPK3—hematologic cancer	1.86e-06	6.73e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—MYC—hematologic cancer	1.85e-06	6.69e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—TGFB1—hematologic cancer	1.84e-06	6.67e-05	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—PIK3CD—hematologic cancer	1.84e-06	6.64e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—CREBBP—hematologic cancer	1.82e-06	6.6e-05	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—ALB—hematologic cancer	1.81e-06	6.56e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—MYC—hematologic cancer	1.81e-06	6.54e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—TGFB1—hematologic cancer	1.8e-06	6.53e-05	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—PIK3R1—hematologic cancer	1.73e-06	6.27e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—PIK3CD—hematologic cancer	1.73e-06	6.26e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—KRAS—hematologic cancer	1.71e-06	6.18e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—ALB—hematologic cancer	1.71e-06	6.18e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—KRAS—hematologic cancer	1.67e-06	6.04e-05	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—PIK3CA—hematologic cancer	1.66e-06	6.02e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—PIK3R1—hematologic cancer	1.63e-06	5.91e-05	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—PIK3CB—hematologic cancer	1.6e-06	5.79e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—PIK3CA—hematologic cancer	1.57e-06	5.68e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—PIK3CA—hematologic cancer	1.54e-06	5.55e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—TP53—hematologic cancer	1.52e-06	5.49e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—PIK3CB—hematologic cancer	1.51e-06	5.46e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—TP53—hematologic cancer	1.49e-06	5.37e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—HRAS—hematologic cancer	1.45e-06	5.25e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—HRAS—hematologic cancer	1.42e-06	5.14e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—IL6—hematologic cancer	1.39e-06	5.03e-05	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—PTEN—hematologic cancer	1.38e-06	5e-05	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—AKT1—hematologic cancer	1.36e-06	4.92e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—IL6—hematologic cancer	1.36e-06	4.92e-05	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—EP300—hematologic cancer	1.32e-06	4.77e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—PTEN—hematologic cancer	1.3e-06	4.71e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—AKT1—hematologic cancer	1.28e-06	4.64e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—AKT1—hematologic cancer	1.25e-06	4.54e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—EP300—hematologic cancer	1.24e-06	4.5e-05	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—PIK3CA—hematologic cancer	9.76e-07	3.53e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—PIK3CA—hematologic cancer	9.19e-07	3.33e-05	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—AKT1—hematologic cancer	7.97e-07	2.88e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—AKT1—hematologic cancer	7.51e-07	2.72e-05	CbGpPWpGaD
